EUVIMEDEUVIMED entdecken
Crossref

One-Year Comparative Effectiveness and Safety of Upadacitinib vs Risankizumab for Crohn’s Disease

Rahul S Dalal, Alexander D Carlin, Heidy J Cabral, Lindsay M Clarke, Grace B Hardwick, Jessica R Allegretti

Clinical Gastroenterology and Hepatology · 2026-01 · 24 (1) · 255-257.e1

DOI: 10.1016/j.cgh.2025.06.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-01. Verfasst von Rahul S Dalal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massach…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: Brigham and Women's Hospital Center for Diversity & Inclusion.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: rsdalal@bwh.harvard.edu.
  • Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Förderung

  • Brigham and Women's Hospital Center for Diversity & Inclusion

Zitieren

APA

Dalal, R. S., Carlin, A. D., Cabral, H. J., Clarke, L. M., Hardwick, G. B., & Allegretti, J. R. (2026). One-Year Comparative Effectiveness and Safety of Upadacitinib vs Risankizumab for Crohn’s Disease. Clinical Gastroenterology and Hepatology, 24(1), 255-257.e1. https://doi.org/10.1016/j.cgh.2025.06.024

Vancouver

Dalal RS, Carlin AD, Cabral HJ, Clarke LM, Hardwick GB, Allegretti JR. One-Year Comparative Effectiveness and Safety of Upadacitinib vs Risankizumab for Crohn’s Disease. Clinical Gastroenterology and Hepatology. 2026;24(1):255-257.e1. doi:10.1016/j.cgh.2025.06.024

BibTeX
@article{Dalal2026,
  author = {Dalal, Rahul S and Carlin, Alexander D and Cabral, Heidy J and Clarke, Lindsay M and Hardwick, Grace B and Allegretti, Jessica R},
  title = {One-Year Comparative Effectiveness and Safety of Upadacitinib vs Risankizumab for Crohn’s Disease},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {1},
  pages = {255--257.e1},
  doi = {10.1016/j.cgh.2025.06.024}
}
Kostenlos starten →